| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arbutus Biopharma Corp (ABUS) has 1 insider with recent SEC Form 4 filings, including 0 buys and 10 sells. ABUS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 157.6K | $690.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2025 | Hastings David C | Chief Financial Officer | Sell | 22,183 | $3.28 | $72,826.79 | -12.2% | +4.5% | +15.5% | |
| Feb 4, 2025 | Sims Karen | Chief Medical Officer | Sell | 19,348 | $3.28 | $63,519.48 | -15.4% | +4.5% | +15.5% | |
| Feb 4, 2025 | McElhaugh Michael J. | Interim President &CEO | Sell | 23,790 | $3.28 | $78,102.57 | -1.6% | +4.5% | +15.5% | |
| Feb 4, 2025 | Naftzger J. Christopher | General Counsel And CCO | Sell | 11,333 | $3.28 | $37,206.24 | -11.6% | +4.5% | +15.5% | |
| Aug 14, 2024 | Manchester Keith S49 | Director | Sale+OE | 8,846 | $3.69 | $32,637.32 | -16.1% | -1.1% | -8.4% | |
| Feb 2, 2024 | Sims Karen | Chief Medical Officer | Sell | 4,358 | $2.31 | $10,077.88 | -3.4% | +12.6% | +39.9% | |
| Feb 2, 2024 | Hastings David C | Chief Financial Officer | Sell | 9,593 | $2.31 | $22,183.81 | -5.0% | +12.6% | +39.9% | |
| Feb 2, 2024 | Sofia Michael J. | Chief Scientific Officer | Sell | 9,982 | $2.31 | $23,083.38 | -0.7% | +12.6% | +39.9% | |
| Feb 2, 2024 | McElhaugh Michael J. | Interim President &CEO | Sell | 10,164 | $2.31 | $23,504.25 | -0.7% | +12.6% | +39.9% | |
| Dec 1, 2021 | Sofia Michael J. | Chief Scientific Officer | Sell | 200,000 | $5.09 | $1,018,000.00 | -13.3% | -32.8% | -49.5% |